SARS-CoV-2 coronavirus spike protein under siege

SARS-CoV-2 coronavirus spike protein under siege

SARS-COV-2 entry depends on N-glycans present in the Spike protein #Code: 252Подробнее

SARS-COV-2 entry depends on N-glycans present in the Spike protein #Code: 252

3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccinesПодробнее

3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccines

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike ProteinПодробнее

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein

Nanobodies attaching to the coronavirus 'spike' protein #ShortsПодробнее

Nanobodies attaching to the coronavirus 'spike' protein #Shorts

COVID-19 vaccines and the spike protein of SARS-CoV-2 #AskDrBen #CoronavirusQuestionsПодробнее

COVID-19 vaccines and the spike protein of SARS-CoV-2 #AskDrBen #CoronavirusQuestions

Activation of the complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibitionПодробнее

Activation of the complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

Sophie Gobeil, Ph.D - Structural, biophysical, and biochemical studies of SARS-CoV-2 spike variantsПодробнее

Sophie Gobeil, Ph.D - Structural, biophysical, and biochemical studies of SARS-CoV-2 spike variants

SARS-COV-2 spike protein and ACE2 receptor simulated bindingПодробнее

SARS-COV-2 spike protein and ACE2 receptor simulated binding

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivityПодробнее

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

Новости